|
WO2021045180A1
|
|
Gastric cancer marker and examination method using same
|
|
WO2021045189A1
|
|
Colorectal cancer marker, and test method using same
|
|
WO2021039889A1
|
|
Pathology image management system
|
|
WO2020218121A1
|
|
Cancer detection method and detection reagent
|
|
WO2020138486A1
|
|
Vegf-a/vegfr2 pathway dual inhibition treatment, and pharmaceutical composition used for same
|
|
WO2020075816A1
|
|
Function mechanism of glyceollin i and utilization thereof
|
|
WO2020013097A1
|
|
Sugar chain specific to prostate cancer, and test method using same
|
|
WO2020009175A1
|
|
Method for inspecting for tankyrase inhibitor sensitivity, pharmaceutical composition enhancing effect thereof, and pharmaceutical screening method
|
|
WO2020188836A1
|
|
Anti-podoplanin antibody
|
|
JP2020112452A
|
|
Peripheral circulating tumor cell and rare cell concentration device
|
|
US2021060016A1
|
|
Anticancer agent
|
|
JP2020068750A
|
|
Methods for examining colorectal cancer
|
|
US2020337537A1
|
|
Image diagnosis assistance apparatus, data collection method, image diagnosis assistance method, and image diagnosis assistance program
|
|
WO2019082871A1
|
|
Method for simultaneously detecting multiple chromosomal abnormalities in single target cell
|
|
WO2019045016A1
|
|
High-sensitivity, quantitative gene examination method, primer set, and examination kit
|
|
WO2018212071A1
|
|
Prognostic predictor for diffuse large b-cell lymphoma and prognosis prediction method
|
|
JP2019133540A
|
|
System for supporting search of anonymized medical information, using integration and management database for structuralized diagnosis data
|
|
US2020355699A1
|
|
Biomarkers, test method, and test kit for predicting therapeutic effect of anti-vegfr-2 antibody drug
|
|
US2019310258A1
|
|
Biomarker, method for searching disease-related gene, and renal cancer marker
|
|
WO2017213117A1
|
|
Multiple staining method and staining kit
|
